STOCK TITAN

Inspire Medical Systems (INSP) grants director 383 common shares as fees

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Broader Shelley G reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems, Inc. reported that director Shelley G. Broader received a grant of 383 shares of common stock on 2026-07-15, issued at $0.0000 per share as equity compensation in lieu of cash fees. Following this award, she directly holds 8,854 shares of the company's common stock.

Positive

  • None.

Negative

  • None.
Insider Broader Shelley G
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 383 $0.00 --
Holdings After Transaction: Common Stock — 8,854 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares granted 383 shares Common stock grant to director Shelley G. Broader on 2026-07-15
Grant price per share $0.0000 per share Equity compensation issued in lieu of cash director fees
Shares held after transaction 8,854 shares Direct holdings of Shelley G. Broader following the reported award
Transaction date 2026-07-15 Date of common stock grant reported for Shelley G. Broader
Non-Employee Director Compensation Policy financial
"pursuant to the Company's Non-Employee Director Compensation Policy."
in lieu of cash fees financial
"shares of common stock received in lieu of cash fees pursuant to"
power of attorney regulatory
"Exhibit 24 - Power of Attorney."
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Shelley G. Broader?

Shelley G. Broader received a grant of 383 shares of Inspire Medical Systems common stock on 2026-07-15 as equity compensation. The shares were issued at $0.0000 per share in lieu of cash fees under the non-employee director compensation policy.

How many Inspire Medical Systems (INSP) shares did Shelley G. Broader receive in this Form 4 filing?

She was awarded 383 shares of Inspire Medical Systems common stock. These shares represent compensation for board service and were received instead of cash fees, increasing her direct ownership position reported in the filing.

Was Shelley G. Broader’s Inspire Medical Systems (INSP) transaction an open-market purchase?

No. The filing shows a code "A" transaction, indicating a grant or award of 383 shares of common stock. A footnote explains the shares were received in lieu of cash fees under the Non-Employee Director Compensation Policy, not bought on the open market.

What are Shelley G. Broader’s Inspire Medical Systems (INSP) holdings after this grant?

After the reported award, Shelley G. Broader directly holds 8,854 shares of Inspire Medical Systems common stock. This post-transaction balance reflects the addition of the 383-share equity compensation grant disclosed in the Form 4.

Was the Inspire Medical Systems (INSP) stock grant to Shelley G. Broader under a Rule 10b5-1 trading plan?

The Form 4 indicates the transaction was not made pursuant to a Rule 10b5-1 plan. Instead, it is characterized as a routine equity compensation grant in lieu of cash fees under the company’s Non-Employee Director Compensation Policy.

What type of security is involved in Shelley G. Broader’s Inspire Medical Systems (INSP) transaction?

The transaction involves common stock of Inspire Medical Systems. A total of 383 shares were granted as non-employee director compensation, with no derivatives or options reported in connection with this specific Form 4 transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Broader Shelley G

(Last)(First)(Middle)
C/O INSPIRE MEDICAL SYSTEMS, INC.
5500 WAYZATA BLVD., SUITE 1600

(Street)
GOLDEN VALLEY MINNESOTA 55416

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/15/2026A383(1)A$08,854D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.
Remarks:
Exhibit 24 - Power of Attorney.
/s/ Bryan Phillips, Attorney-in-Fact for Shelley G. Broader07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)